arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

The Cooper Companies, Inc.

COO Health Care Ophthalmic Goods
$61.65
▲ +4.3% Today
as of Oct 22, 16:47 ET
Last 30 days +13.70% Sep 14 → Oct 22
$52.60 $55.03 $57.46 $59.89 $62.32 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$59.39
High
$61.66
Low
$59.27
Volume
$4M
Avg Vol
$3M
Mkt Cap
$13.6B
P/E (TTM)
23.18
Beta
—
52w High
$89.83
52w Low
$51.01
Div Yield
—
Shares Out
$190M

Recent Press Releases & News last 60 days · 25 items

Oct 14 · 15:32 StockStory
Medical Devices & Supplies - Diversified Stocks Q2 Highlights: CooperCompanies (NASDAQ:COO)
Oct 9 · 14:30 Zacks
Why Is The Cooper Companies (COO) Up 0.2% Since Last Earnings Report?
Sep 28 · 01:49 Insider Monkey
Is Jana Partners Right that Cooper (COO) Needs a Different Kind of Leadership?
▸ Show all 25 press releases & news Free account →

COO earnings at a glance

The options market is pricing a move of about ±3.9% after the report, a range of roughly $59.23 to $64.07 from today's $61.65. Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±0.2% on average; after the most recent report on May 29, 2025 it moved -0.2%. That means options currently expect more movement than COO has typically delivered. COO beat the consensus EPS estimate in 2 of its last 2 reported quarters. Implied volatility is currently 31%. The share price of $61.65 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$51
$90
27% of range
Avg surprise (last 2)
+3.0%
Avg reaction (last 1)
-0.2%
0% positive
Latest IV / EM
31%
EM ±3.9% · $55 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.40$0.26$0.92$1.58$2.24 Actual $0.43Actual $0.20Actual $0.43Actual $0.41Actual $0.44Actual $0.52Actual $0.52Actual $0.96Est $0.93Actual $1.10Est $1.07Actual $0.66Actual $-0.40Actual $2.24 JanAprJulJanAprJulJanApr/2025Jul/2025JanAprJul
Revenue vs Net Income Revenue Net income
$-78M$225M$529M$832M$1.1B Jan 25Apr 25Jul 25Jan 26Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Jul 31, 2026Jul 2026 $2.24 — — — — financials
Thu Apr 30, 2026Apr 2026 $-0.40 — — — — financials
Sat Jan 31, 2026Jan 2026 $0.66 — — — — financials
Wed Aug 27, 2025Jul/2025 $1.10 $1.07 +2.8% — — earnings
Thu May 29, 2025Apr/2025 $0.96 $0.93 +3.2% — -0.2% earnings
Fri Jan 31, 2025Jan 2025 $0.52 — — — — financials
Wed Jul 31, 2024Jul 2024 $0.52 — — — — financials
Tue Apr 30, 2024Apr 2024 $0.44 — — — — financials
Wed Jan 31, 2024Jan 2024 $0.41 — — — — financials
Mon Jul 31, 2023Jul 2023 $0.43 — — — — financials
Sun Apr 30, 2023Apr 2023 $0.20 — — — — financials
Tue Jan 31, 2023Jan 2023 $0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue$1.07B$1.08B$1.02B—$1.06B$1.00B$965M—
Cost of revenue$354M$346M$329M—$368M$323M$304M—
Gross profit$712M$735M$695M—$692M$679M$660M—
Operating income$222M$-31M$213M—$176M$185M$182M—
Net income$433M$-78M$131M—$98M$88M$104M—
EPS (diluted)$2.24$-0.40$0.66—$0.49$0.44$0.52—

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Cash & equivalents$155M$139M$125M$111M$125M$116M$101M$108M
Inventory$912M$896M$876M$846M$881M$880M$843M$803M
Total current assets$2.28B$2.30B$2.13B$2.11B$2.14B$2.13B$1.99B$1.95B
Total assets$12.67B$12.48B$12.42B$12.39B$12.38B$12.41B$12.22B$12.32B
Long-term debt$1.91B$1.86B$1.88B$2.46B$2.43B$2.52B$2.49B$2.55B
Total liabilities$4.34B$4.24B$4.06B$4.16B$4.02B$4.13B$4.09B$4.23B
Total equity$8.33B$8.24B$8.36B$8.24B$8.35B$8.29B$8.13B$8.08B

Implied volatility — last 90 days

20%72%125%178%230% Jun 06 — IV 54% · EM ±9.8%Jun 07 — IV 90% · EM ±12.4%Jun 08 — IV 42% · EM ±5.5%Jun 09 — IV 38% · EM ±4.8%Jun 10 — IV 46% · EM ±5.4%Jun 11 — IV 47% · EM ±5.2%Jun 12 — IV 48% · EM ±4.9%Jun 15 — IV 97% · EM ±7.0%Jun 16 — IV 141% · EM ±8.3%Jun 17 — IV 56% · EM ±2.3%Jun 19 — IV 33% · EM ±7.3%Jun 22 — IV 32% · EM ±6.6%Jun 23 — IV 34% · EM ±7.0%Jun 24 — IV 26% · EM ±5.1%Jun 25 — IV 34% · EM ±6.6%Jun 26 — IV 28% · EM ±5.4%Jun 29 — IV 43% · EM ±7.7%Jun 30 — IV 28% · EM ±4.9%Jul 01 — IV 45% · EM ±7.5%Jul 02 — IV 24% · EM ±3.9%Jul 03 — IV 25% · EM ±3.9%Jul 06 — IV 44% · EM ±6.1%Jul 07 — IV 50% · EM ±6.6%Jul 08 — IV 24% · EM ±3.0%Jul 09 — IV 39% · EM ±4.6%Jul 10 — IV 44% · EM ±4.9%Jul 13 — IV 65% · EM ±5.5%Jul 14 — IV 74% · EM ±5.3%Jul 15 — IV 31% · EM ±1.8%Jul 16 — IV 79% · EM ±3.3%Jul 20 — IV 34% · EM ±8.1%Jul 21 — IV 36% · EM ±8.4%Jul 22 — IV 29% · EM ±6.7%Jul 23 — IV 31% · EM ±7.0%Jul 24 — IV 39% · EM ±8.7%Jul 27 — IV 33% · EM ±6.8%Jul 28 — IV 40% · EM ±8.2%Jul 29 — IV 30% · EM ±5.9%Jul 30 — IV 29% · EM ±5.6%Jul 31 — IV 44% · EM ±8.5%Aug 03 — IV 26% · EM ±4.6%Aug 04 — IV 27% · EM ±4.7%Aug 05 — IV 23% · EM ±3.8%Aug 06 — IV 24% · EM ±3.9%Aug 07 — IV 20% · EM ±3.1%Aug 10 — IV 25% · EM ±3.5%Aug 11 — IV 48% · EM ±6.4%Aug 12 — IV 47% · EM ±5.9%Aug 13 — IV 45% · EM ±5.4%Aug 14 — IV 40% · EM ±4.4%Aug 17 — IV 20% · EM ±1.7%Aug 18 — IV 46% · EM ±3.3%Aug 19 — IV 81% · EM ±4.8%Aug 20 — IV 85% · EM ±3.5%Aug 24 — IV 39% · EM ±8.1%Aug 25 — IV 69% · EM ±14.1%Aug 26 — IV 45% · EM ±9.0%Aug 27 — IV 46% · EM ±9.0%Aug 28 — IV 42% · EM ±8.0%Aug 31 — IV 50% · EM ±8.8%Sep 01 — IV 49% · EM ±8.4%Sep 02 — IV 49% · EM ±8.2%Sep 03 — IV 43% · EM ±7.0%Sep 04 — IV 54% · EM ±8.4%Sep 07 — IV 60% · EM ±8.4%Sep 08 — IV 54% · EM ±7.1%Sep 09 — IV 120% · EM ±15.0%Sep 10 — IV 36% · EM ±4.3%Sep 11 — IV 32% · EM ±3.5%Sep 14 — IV 38% · EM ±3.2%Sep 15 — IV 92% · EM ±6.7%Sep 16 — IV 40% · EM ±2.3%Sep 17 — IV 124% · EM ±5.2%Sep 21 — IV 33% · EM ±6.8%Sep 22 — IV 29% · EM ±5.9%Sep 23 — IV 28% · EM ±5.6%Sep 24 — IV 32% · EM ±6.3%Sep 25 — IV 24% · EM ±4.5%Sep 28 — IV 34% · EM ±6.1%Sep 29 — IV 47% · EM ±8.1%Sep 30 — IV 231% · EM ±38.6%Oct 01 — IV 35% · EM ±5.6%Oct 02 — IV 35% · EM ±5.5%Oct 06 — IV 43% · EM ±5.7%Oct 07 — IV 31% · EM ±3.9%

Sector peers

BLCO
Bausch + Lomb Corporation
$6.2B $17.43+3.0%
WRBY
Warby Parker Inc.
$3.1B $25.67+0.2%
EYE
National Vision Holdings, Inc.
$1.3B $18.87+5.1%
STAA
STAAR Surgical Company
$1.1B $22.49+0.8%
RXST
RxSight, Inc.
$200M $5.08+4.1%
LUCY
Innovative Eyewear, Inc.
$8M $0.86+3.6%

COO earnings FAQ

What is COO's expected move for earnings?

Options currently price a move of about ±3.9%, or $2.42 per share either way from $61.65.

How does COO stock usually react to earnings?

Across the last 1 reports the average next-day move was ±0.2%, up 0 times and down 1 times.

What is COO's implied volatility?

COO's at-the-money implied volatility is about 31% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in